The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abaxis, Inc. | Common | 002567105 | 1,157 | 22,466 | SH | SOLE | 22,466 | 0 | 0 | ||
AbbVie Inc. | Common | 00287Y109 | 10 | 156 | SH | SOLE | 156 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 15,496 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | ||
Accelerate Diagnostics, Inc. | Common | 00430H102 | 3,733 | 144,625 | SH | SOLE | 144,625 | 0 | 0 | ||
Achillion Pharmaceuticals Inc | Common | 00448Q201 | 4,849 | 547,300 | SH | SOLE | 547,300 | 0 | 0 | ||
Acorda Therapeutics, Inc. | Common | 00484M106 | 22,693 | 680,862 | SH | SOLE | 680,862 | 0 | 0 | ||
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 504 | 27,500 | SH | SOLE | 27,500 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | Common | 00767E102 | 3,908 | 206,000 | SH | SOLE | 206,000 | 0 | 0 | ||
Aetna, Inc. | Common | 00817Y108 | 42,308 | 331,931 | SH | SOLE | 331,931 | 0 | 0 | ||
Akorn, Inc. | Common | 009728106 | 37,088 | 849,482 | SH | SOLE | 849,482 | 0 | 0 | ||
Alere, Inc. | Common | 01449J105 | 15,714 | 297,901 | SH | SOLE | 297,901 | 0 | 0 | ||
Alexion Pharmaceuticals plc | Common | 015351109 | 105,625 | 584,305 | SH | SOLE | 584,305 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 66,622 | 1,035,470 | SH | SOLE | 1,035,470 | 0 | 0 | ||
Allergan plc | Shares | G0177J108 | 104,295 | 343,686 | SH | SOLE | 343,686 | 0 | 0 | ||
Allergan plc | Preferred Convertible | G0177J116 | 5,213 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
Alliqua BioMedical, Inc. | Common | 019621200 | 8,696 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | ||
Allscripts Healthcare Solutions, Inc. | Common | 01988P108 | 24,326 | 1,778,200 | SH | SOLE | 1,778,200 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 12,406 | 103,495 | SH | SOLE | 103,495 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 76,342 | 497,280 | SH | SOLE | 497,280 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 22,414 | 146,000 | SH | Call | SOLE | 146,000 | 0 | 0 | |
Auris Medical Holding AG | Common | H03579101 | 10,400 | 2,105,263 | SH | SOLE | 2,105,263 | 0 | 0 | ||
Baxter International, Inc. | Common | 071813109 | 22,350 | 319,600 | SH | SOLE | 319,600 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 1,276 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
BioDelivery Sciences International, Inc. | Common | 09060J106 | 1,990 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 142,685 | 353,233 | SH | SOLE | 353,233 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 73,174 | 534,977 | SH | SOLE | 534,977 | 0 | 0 | ||
bluebird bio, Inc. | Common | 09609G100 | 6,885 | 40,895 | SH | SOLE | 40,895 | 0 | 0 | ||
Bristol-Myers Squibb Co. | Common | 110122108 | 35,615 | 535,240 | SH | SOLE | 535,240 | 0 | 0 | ||
Catamaran Corporation | Common | 148887102 | 26,484 | 433,600 | SH | SOLE | 433,600 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 223,280 | 1,929,234 | SH | SOLE | 1,929,234 | 0 | 0 | ||
Cellectis S.A. | Sponsored ADS | 15117K103 | 1,443 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
Centene Corporation | Common | 15135B101 | 9,648 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
Cidara Therapeutics, Inc. | Common | 171757107 | 701 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
Cigna Corporation | Common | 125509109 | 12,029 | 74,251 | SH | SOLE | 74,251 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 13,197 | 209,572 | SH | SOLE | 209,572 | 0 | 0 | ||
Corsicanto Ltd. | Note 3.5% 1/15/32 | 220480AB3 | 15,803 | 14,700,000 | PRN | SOLE | 14,700,000 | 0 | 0 | ||
Dermira, Inc. | Common | 24983L104 | 1,706 | 97,197 | SH | SOLE | 97,197 | 0 | 0 | ||
Endo International PLC | Shares | G30401106 | 25,956 | 325,873 | SH | SOLE | 325,873 | 0 | 0 | ||
Endo International PLC | Shares | G30401106 | 5,902 | 74,100 | SH | Call | SOLE | 74,100 | 0 | 0 | |
Endologix Inc. | Common | 29266S106 | 8,452 | 551,000 | SH | SOLE | 551,000 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 4,800 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Esperion Therapeutics, Inc. | Common | 29664W105 | 12,100 | 148,000 | SH | SOLE | 148,000 | 0 | 0 | ||
Esperion Therapeutics, Inc. | Common | 29664W105 | 12,100 | 148,000 | SH | Call | SOLE | 148,000 | 0 | 0 | |
Flex Pharma, Inc. | Common | 33938A105 | 4,001 | 232,600 | SH | SOLE | 232,600 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd. | Shares | M46135105 | 4,241 | 413,800 | SH | SOLE | 413,800 | 0 | 0 | ||
Galapagos NV | Sponsored ADR | 36315X101 | 1,030 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
GenMark Diagnostics, Inc. | Common | 372309104 | 1,949 | 215,149 | SH | SOLE | 215,149 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 243,495 | 2,079,731 | SH | SOLE | 2,079,731 | 0 | 0 | ||
HCA Holdings, Inc. | Common | 40412C101 | 19,395 | 213,788 | SH | SOLE | 213,788 | 0 | 0 | ||
HCA Holdings, Inc. | Common | 40412C101 | 6,015 | 66,300 | SH | Call | SOLE | 66,300 | 0 | 0 | |
Health Care REIT Inc. | Common | 42217K601 | 11,888 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Heron Therapeutics, Inc. | Common | 427746102 | 13,616 | 436,970 | SH | SOLE | 436,970 | 0 | 0 | ||
Humana, Inc. | Common | 444859102 | 21,423 | 112,000 | SH | SOLE | 112,000 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 8,489 | 132,352 | SH | SOLE | 132,352 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 50,144 | 229,641 | SH | SOLE | 229,641 | 0 | 0 | ||
Impax Laboratories, Inc. | Common | 45256B101 | 15,828 | 344,683 | SH | SOLE | 344,683 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 91,753 | 880,461 | SH | SOLE | 880,461 | 0 | 0 | ||
IntelliPharmaceutics International Inc. | Common | 458173101 | 1,041 | 354,047 | SH | SOLE | 354,047 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 7,258 | 227,164 | SH | SOLE | 227,164 | 0 | 0 | ||
Ironwood Pharmaceuticals, Inc. | Common | 46333X108 | 9,263 | 768,050 | SH | SOLE | 768,050 | 0 | 0 | ||
Ishares Nasdaq Biotechnology ETF | ETF | 464287556 | 21,278 | 57,670 | SH | SOLE | 57,670 | 0 | 0 | ||
Isis Pharmaceuticals, Inc. | Common | 464330109 | 5,651 | 98,200 | SH | SOLE | 98,200 | 0 | 0 | ||
Isis Pharmaceuticals, Inc. | Common | 464330109 | 5,651 | 98,200 | SH | Call | SOLE | 98,200 | 0 | 0 | |
Jazz Pharmaceuticals plc | Shares | G50871105 | 21,191 | 120,357 | SH | SOLE | 120,357 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 86,214 | 884,612 | SH | SOLE | 884,612 | 0 | 0 | ||
Karyopharm Therapeutics Inc. | Common | 48576U106 | 12,978 | 476,966 | SH | SOLE | 476,966 | 0 | 0 | ||
Kite Pharma, Inc. | Common | 49803L109 | 384 | 6,300 | SH | SOLE | 6,300 | 0 | 0 | ||
KYTHERA Biopharmaceuticals Inc. | Common | 501570105 | 4,196 | 55,717 | SH | SOLE | 55,717 | 0 | 0 | ||
LTC Properties Inc. | Common | 502175102 | 9,843 | 236,618 | SH | SOLE | 236,618 | 0 | 0 | ||
MacroGenics, Inc. | Common | 556099109 | 484 | 12,743 | SH | SOLE | 12,743 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 15,256 | 67,862 | SH | SOLE | 67,862 | 0 | 0 | ||
Medical Properties Trust Inc. | Common | 58463J304 | 15,123 | 1,153,574 | SH | SOLE | 1,153,574 | 0 | 0 | ||
Medivation, Inc | Common | 58501N101 | 6,133 | 53,700 | SH | SOLE | 53,700 | 0 | 0 | ||
Medivation, Inc | Common | 58501N101 | 6,133 | 53,700 | SH | Call | SOLE | 53,700 | 0 | 0 | |
Merck & Co., Inc. | Common | 58933Y105 | 10,532 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
Merrimack Pharmaceuticals, Inc. | Note 4.50% 7/15/20 | 590328AA8 | 3,113 | 1,485,000 | PRN | SOLE | 1,485,000 | 0 | 0 | ||
Merrimack Pharmaceuticals, Inc. | Common | 590328100 | 7,021 | 567,787 | SH | SOLE | 567,787 | 0 | 0 | ||
Molina Healthcare, Inc. | Common | 60855R100 | 24,457 | 347,901 | SH | SOLE | 347,901 | 0 | 0 | ||
Mylan NV | Shares Euro | N59465109 | 124,659 | 1,837,005 | SH | SOLE | 1,837,005 | 0 | 0 | ||
Mylan NV | Shares Euro | N59465109 | 11,699 | 172,400 | SH | Call | SOLE | 172,400 | 0 | 0 | |
Myriad Genetics, Inc. | Common | 62855J104 | 2,542 | 74,800 | SH | SOLE | 74,800 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 17,951 | 375,860 | SH | SOLE | 375,860 | 0 | 0 | ||
Omega Healthcare Investors Inc. | Common | 681936100 | 14,182 | 413,116 | SH | SOLE | 413,116 | 0 | 0 | ||
OncoGenex Pharmaceuticals, Inc. | Common | 68230A106 | 264 | 113,100 | SH | SOLE | 113,100 | 0 | 0 | ||
Paratek Pharmaceuticals, Inc. | Common | 699374302 | 17,807 | 691,000 | SH | SOLE | 691,000 | 0 | 0 | ||
Pfizer, Inc. | Common | 717081103 | 54,930 | 1,638,241 | SH | SOLE | 1,638,241 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 16,142 | 1,050,902 | SH | SOLE | 1,050,902 | 0 | 0 | ||
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 10,583 | 3,848,191 | SH | SOLE | 3,848,191 | 0 | 0 | ||
Receptos, Inc. | Common | 756207106 | 23,718 | 124,800 | SH | SOLE | 124,800 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 95,479 | 187,166 | SH | SOLE | 187,166 | 0 | 0 | ||
Sabra Health Care REIT Inc. | Common | 78573L106 | 11,742 | 456,190 | SH | SOLE | 456,190 | 0 | 0 | ||
Sage Therapeutics, Inc. | Common | 78667J108 | 1,095 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
Sagent Pharmaceuticals, Inc. | Common | 786692103 | 9,955 | 409,500 | SH | SOLE | 409,500 | 0 | 0 | ||
Sangamo BioSciences, Inc. | Common | 800677106 | 832 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
Senior Housing Properties Trust | Shares | 81721M109 | 8,417 | 479,604 | SH | SOLE | 479,604 | 0 | 0 | ||
Spectrum Pharmaceuticals, Inc. | Note 2.75% 12/15/18 | 84763AAB4 | 4,694 | 5,000,000 | PRN | SOLE | 5,000,000 | 0 | 0 | ||
St Jude Medical, Inc. | Common | 790849103 | 11,802 | 161,510 | SH | SOLE | 161,510 | 0 | 0 | ||
Stryker Corporation | Common | 863667101 | 11,845 | 123,940 | SH | SOLE | 123,940 | 0 | 0 | ||
Supernus Pharmaceuticals, Inc. | Note 7.50% 5/1/19 | 868459AB4 | 6,655 | 2,000,000 | PRN | SOLE | 2,000,000 | 0 | 0 | ||
Tenet Healthcare Corporation | Common | 88033G407 | 9,521 | 164,500 | SH | SOLE | 164,500 | 0 | 0 | ||
Tenet Healthcare Corporation | Common | 88033G407 | 6,077 | 105,000 | SH | Call | SOLE | 105,000 | 0 | 0 | |
TetraLogic Pharmaceuticals Corporation | Note 8.00% 6/15/19 | 88165UAB5 | 2,658 | 4,500,000 | PRN | SOLE | 4,500,000 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | ADR | 881624209 | 82,007 | 1,387,594 | SH | SOLE | 1,387,594 | 0 | 0 | ||
TherapeuticsMD, Inc. | Common | 88338N107 | 11,645 | 1,481,500 | SH | SOLE | 1,481,500 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 11,211 | 86,395 | SH | SOLE | 86,395 | 0 | 0 | ||
Trillium Therapeutics Inc. | Common | 89620X506 | 1,418 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 6,143 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
Ventas Inc. | Common | 92276F100 | 18,179 | 292,782 | SH | SOLE | 292,782 | 0 | 0 | ||
Verastem, Inc. | Common | 92337C104 | 9,424 | 1,249,827 | SH | SOLE | 1,249,827 | 0 | 0 | ||
Vertex Pharmaceuticals, Inc. | Common | 92532F100 | 110,873 | 897,903 | SH | SOLE | 897,903 | 0 | 0 | ||
WellCare Health Plans Inc. | Common | 94946T106 | 7,520 | 88,652 | SH | SOLE | 88,652 | 0 | 0 | ||
Wright Medical Group Inc. | Common | 98235T107 | 4,099 | 156,100 | SH | SOLE | 156,100 | 0 | 0 | ||
Xencor, Inc. | Common | 98401F105 | 439 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Zafgen, Inc. | Common | 98885E103 | 461 | 13,307 | SH | SOLE | 13,307 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 11,174 | 102,300 | SH | SOLE | 102,300 | 0 | 0 | ||
Zogenix, Inc. | Common | 98978L105 | 6,385 | 3,800,811 | SH | SOLE | 3,800,811 | 0 | 0 |